Heritage Marijuana Indications Letter of Intent with IntelGenx for Long-Term Marijuana Filmstrip Supply ... 1
< img src=" http://cbdgreenbuds.com/wp-content/uploads/2020/10/hKkaWj.jpg" > By enriquelopezgarre from Pixabay

< a href=" https://www.google.com/url?rct=j&sa=t&url=https://www.businesswire.com/news/home/20201029005182/en/Heritage-Cannabis-Signs-Letter-of-Intent-with-IntelGenx-for-Long-Term-Cannabis-Filmstrip-Supply-Agreement&ct=ga&cd=CAIyGmI2YWQ0MjEwNTVkZTI5ZWU6Y29tOmVuOlVT&usg=AFQjCNEsGUswai-cMwyErYXSJWrn3W9k4g" > Heritage Marijuana Signs Letter of Intent with IntelGenx for Long-Term Cannabis Filmstrip Supply …

TORONTO–( (TSXV: IGX) (OTCQB: IGXT )( “IntelGenx” ), a leading drug delivery company focused on the development and production of pharmaceutical movies, for the supply of filmstrip products consisting of CBD(” CBD Filmstrips “) for the Canadian and Australian markets. Pursuant to the LOI and topic to getting in into a Definitive Supply Contract and the fulfillment of popular closing conditions, IntelGenx will make filmstrips including 10 mg of CBD using its VersaFilm ® technology, for distribution and sale in Canada and Australia. In addition to getting a manufacturing margin, IntelGenx will also get a double-digit royalty on the gross margin based on item sales. Heritage will provide CBD product for IntelGenx’s filmstrip manufacture and supply in Canada and Australia on a non -and semi-exclusive basis, respectively. The LOI considers a choice on future co-development of CBD and THC filmstrips utilizing proprietary technology from both companies, under particular conditions. The CBD Filmstrips will be produced at IntelGenx’s production center under Canadian GPP conditions and signed up as an item for sale with Health Canada as a marijuana product governed by the Cannabis Act and with the Australian Department of Health’s Therapeutic Product Administration as a medicinal cannabis item governed by the Narcotic Drugs Act. Clint Sharples, CEO of Heritage, commented,” We value this collaboration with IntelGenx given their leadership in establishing high quality pharmaceutical products with their exclusive filmstrip platforms. This supply deal is an initial step in developing a long-term relationship to establish high quality, information driven and well-tested items for the Canadian and international medical cannabis and hemp markets, including Australia and the United States.” Dr. Horst G. Zerbe, CEO of IntelGenx, commented, “This LOI even more supports the potential of our VersaFilm ® technology to supply medical marijuana consumers with an alternative, more discreet and practical administration method, with the possibility of a remarkable healing profile.

” About Heritage Cannabis Holdings Corp. Heritage Cannabis is a vertically incorporated marijuana company that currentlyhas two Health Canada authorized certified producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both controlled under the Cannabis Act Laws. Working under these two licenses,

Heritage has two additional subsidiaries, Purefarma Solutions, which supplies extraction services, and a Medical Providers Division which is focused on cannabis based medical options. In the U.S, Heritage operates under Opticann Inc., a Colorado based oral and topical cannabinoid company with the rights to solely sell CBD and CBG items made with the trademarked VESIsorb ® drug shipment system for optimized absorption and stability. As the moms and dad company, Heritage is focused on providing the resources for its subsidiaries to advance their service or products to contend both domestically and internationally. About IntelGenx is a leading drug delivery company concentrated on the development and manufacturing of pharmaceutical films. IntelGenx’s remarkable movie technologies, including VersaFilm ® and VetaFilm ™, in addition to VevaDermTM, its transdermal advancement and manufacturing abilities, permit next generation pharmaceutical products that resolve unmet medical needs. IntelGenx’s innovative item pipeline offers substantial
advantages to patients and physicians for many healing conditions. IntelGenx’s extremely proficient team offers extensive pharmaceuticals services to pharmaceutical partners, consisting of R&D, analytical technique development, scientific tracking, IP and regulatory services. IntelGenx’s modern manufacturing center offers complete service by offering lab-scale to pilot- and commercial-scale production. To find out more, see www.intelgenx.com. ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.” Clint Sharples “CEO.< img referrerpolicy=" unsafe-url" alt src= "https://cts.businesswire.com/ct/CT?id=bwnews&sty=20201029005182r1&sid=web01&distro=nx&lang=en" > Published at Thu, 29 Oct 2020 12:00:00 +0000

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

CBD Green Buds